BERLIN, June 15, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) is spotlighting its new Halcyon™ radiotherapy treatmentsystem at the 2017 meeting of DEGRO, the German radiation oncology society, which takes place in Berlin from June 15th-18th. In addition to this new treatment device,
Engineered to revolutionize clinical workflow, the Halcyon system simplifies and enhances virtually every aspect of image-guided volumetric intensity modulated radiotherapy (IMRT) for advanced cancer treatments.
"This new treatment system is designed to expand the availability of high quality cancer care globally and help save the lives of millions more cancer patients," says Rolf Staehelin, Varian's managing director in Germany and field VP of sales in Central Europe. "We are very excited with the introduction of Halcyon to be taking another big step toward advancing cost-effective cancer care worldwide."
The driving focus of the human-centered, user-friendly design of Halcyon was to automate, streamline and simplify virtually every aspect of treatment. The result is an advanced system that is more comfortable for the patient while delivering ease of use for healthcare providers, accelerated installation timeframes, expedited commissioning, simplified training, and automated treatment. Halcyon is well suited to handle the majority of cancer patients, offering treatments for prostate, breast, head & neck, and many other forms of cancer. For more information on Halcyon visit www.varian.com/halcyon.
Also on display at the Varian booth will be the company's TrueBeam® platform for radiotherapy and radiosurgery, along with the RapidArc® image-guided intensity-modulated radiotherapy system, as well as Varian's range of advanced brachytherapy software and hardware.
Visitors to the booth will also be able to learn more about the company's new HyperArc™* high-definition radiotherapy system, which exploits specific capabilities of the TrueBeam® and Edge™ platforms and is designed to deliver more compact radiation doses that may fully saturate a targeted tumor and "fall off" sharply outside the target zone, potentially minimizing dose to specific organs requiring more protection.
Additionally, the Varian booth will spotlight the company's ProBeam® system, a fully-integrated image-guided IMPT (intensity-modulated proton therapy) solution, which incorporates pencil-beam scanning technology to optimize the dose applied to every point within the area being treated. ProBeam has been selected to equip multiple proton therapy centers around the world, including several in Europe.
On Friday June 16th, Varian is hosting a lunch symposium at DEGRO discussing the challenges and opportunities of innovation in radiotherapy. A second symposium in the evening will focus on Varian's RapidPlan™ knowledge-based planning software.
*Works in Progress – not yet available for sale
About Varian Medical Systems
Varian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,400 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.
Neil MadleVarian Medical Systems+44 7786 526068 firstname.lastname@example.org
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/varian-spotlights-new-halcyon-radiotherapy-treatment-system-at-degro-2017-300474472.html
SOURCE Varian Medical Systems
Subscribe to our Free Newsletters!
Nocturnal polyuria refers to increased urine output during night, without an associated increase in ...
Nootropics are drugs or substances which improve cognition that are being increasingly used ...
Pterygium or Surfer's eye is described as a proliferative disorder of the ocular surface possibly ...View All